Skip to main content
Fig. 2 | BMC Infectious Diseases

Fig. 2

From: Identification of SARS-CoV-2 variants using viral sequencing for the Centers for Disease Control and Prevention genomic surveillance program

Fig. 2

Genome coverage and ambiguity rates between sequencing instruments. a Distribution of average coverage over genome in samples sequenced using NextSeq550 and NovaSeq600. b Distribution of percent ambiguous nucleotides (masked) in consensus sequence. c Fraction of consensus sequence masked due to nucleotide ambiguity in samples sequenced on NextSeq550 and NovaSeq6000 instruments sequenced on NextSeq550 and NovaSeq600 instruments

Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us